[Treatment of Parkinson's disease with COMT inhibitors: tolcapone]

Cognitive and behavioral disturbances in PSP and MSA: clinical features and imaging correlates.

Journal of neural transmission (Vienna, Austria : 1996)·2026

The discriminative linguistic profiles of progressive supranuclear palsy and Parkinson's disease.

Neurologia·2025

SYNAPSES. A European observational study to evaluate the safety and the effectiveness of safinamide in routine clinical practice: post-hoc analysis of the Spanish study population.

Revista de neurologia·2023

Pharmacological management of Parkinson's disease motor symptoms: update and recommendations from an expert.

Revista de neurologia·2022

Staging Parkinson's Disease Combining Motor and Nonmotor Symptoms Correlates with Disability and Quality of Life.

Parkinson's disease·2021

[DISCREPA study: treatment of advanced Parkinson's disease and use of second-line treatments in Catalonia].

Revista de neurologia·2020

[Neurological complications in critical patients with COVID-19].

Neurologia (Barcelona, Spain)·2024

[Relation between COVID-19 and Guillain-Barré syndrome in adults. Systematic review].

Neurologia (Barcelona, Spain)·2024

[Three-month functional prognosis of patients hospitalised due to acute ischaemic stroke in Aragon: Rregional analysis of the impact of COVID-19].

Neurologia (Barcelona, Spain)·2024

[Smell and taste disorders in Spanish patients with mild COVID-19].

Neurologia (Barcelona, Spain)·2024

[Standard headache and neuralgia treatments and SARS-CoV-2: opinion of the Spanish Society of Neurology's Headache Study Group].

Neurologia (Barcelona, Spain)·2024

[Case fatality of COVID-19 in patients with neurodegenerative dementia].

Neurologia (Barcelona, Spain)·2024

Self-Medication Safety Behaviours and Recognition of Pharmacological Risks: A Clinical Pharmacology Perspective.

Cureus·2026

Haematological toxicity associated with antineoplastic drugs: a pharmacovigilance analysis based on the FDA adverse event reporting system database.

Frontiers in immunology·2026

Parathyroid Surgery for Primary Hyperparathyroidism in 2026.

British journal of hospital medicine (London, England : 2005)·2026

Clinical progress note: Management of the hospitalized patient with medetomidine withdrawal.

Journal of hospital medicine·2026

PPM1H loss alters intrasynaptic alpha-synuclein localization in a LRRK2-dependent manner.

Molecular brain·2026

Practice Variation in the Pharmacologic Management of Severe Alcohol Withdrawal: a Survey of Medical Toxicology and Critical Care Physicians.

Journal of medical toxicology : official journal of the American College of Medical Toxicology·2026

Related Experiment Videos

[Treatment of Parkinson's disease with COMT inhibitors: tolcapone]

Related Concept Videos

Cognitive and behavioral disturbances in PSP and MSA: clinical features and imaging correlates.

The discriminative linguistic profiles of progressive supranuclear palsy and Parkinson's disease.

SYNAPSES. A European observational study to evaluate the safety and the effectiveness of safinamide in routine clinical practice: post-hoc analysis of the Spanish study population.

Pharmacological management of Parkinson's disease motor symptoms: update and recommendations from an expert.

Staging Parkinson's Disease Combining Motor and Nonmotor Symptoms Correlates with Disability and Quality of Life.

[DISCREPA study: treatment of advanced Parkinson's disease and use of second-line treatments in Catalonia].

[Neurological complications in critical patients with COVID-19].

[Relation between COVID-19 and Guillain-Barré syndrome in adults. Systematic review].

[Three-month functional prognosis of patients hospitalised due to acute ischaemic stroke in Aragon: Rregional analysis of the impact of COVID-19].

[Smell and taste disorders in Spanish patients with mild COVID-19].

[Standard headache and neuralgia treatments and SARS-CoV-2: opinion of the Spanish Society of Neurology's Headache Study Group].

[Case fatality of COVID-19 in patients with neurodegenerative dementia].

Self-Medication Safety Behaviours and Recognition of Pharmacological Risks: A Clinical Pharmacology Perspective.

Haematological toxicity associated with antineoplastic drugs: a pharmacovigilance analysis based on the FDA adverse event reporting system database.

Parathyroid Surgery for Primary Hyperparathyroidism in 2026.

Clinical progress note: Management of the hospitalized patient with medetomidine withdrawal.

PPM1H loss alters intrasynaptic alpha-synuclein localization in a LRRK2-dependent manner.

Practice Variation in the Pharmacologic Management of Severe Alcohol Withdrawal: a Survey of Medical Toxicology and Critical Care Physicians.

Related Experiment Videos

[Treatment of Parkinson's disease with COMT inhibitors: tolcapone]

Related Concept Videos

Related Articles